Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 8-K Event Executive or director change
  4. 4 Gift Director gave 7,800 shares (gift)
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 8-K Event Material agreement · Unregistered share sale
  7. 8-K Event Executive or director change
  8. 4 Open-market buy General Counsel bought 9,000 shares at $10.33 ($92,970)
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 8-K Event Results of operations
  11. 10-K Report Annual Report
  12. 8-K Event Regulation FD disclosure
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. EFFECT Other Notice of Effectiveness
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-3/A Offering Registration Statement

Page 24 of 41 · 801 filings